Clinical and Translational Research
Copyright ©The Author(s) 2022.
World J Clin Cases. Mar 6, 2022; 10(7): 2072-2086
Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2072
Figure 3
Figure 3 The prognostic values of the N-Myc downstream-regulated gene family genes-based signature in The Cancer Genome Atlas cohort. A: Distribution of risk scores (top); survival status (middle); gene expression of N-Myc downstream-regulated gene (NDRG)1-3 between low- and high-risk groups (bottom) in The Cancer Genome Atlas cohort; B: Kaplan–Meier overall survival analysis of low and high-risk groups; C: Comparison of gene expression between low and high-risk groups for NDRG1, NDRG2, and NDRG3; D: Receiver operating characteristic curve analysis of the association between NDRG-based signature and 1-, 2-, and 3-year overall survival probability.